Filing Details

Accession Number:
0001127602-12-008088
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-27 16:18:24
Reporting Period:
2012-02-23
Filing Date:
2012-02-27
Accepted Time:
2012-02-27 16:18:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Idec Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1504983 E. Robert Gagnon Biogen Idec Inc.
133 Boston Post Road
Weston MA 02493
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-23 1,223 $0.00 6,273 No 4 M Direct
Common Stock Disposition 2012-02-23 388 $116.70 5,885 No 4 F Direct
Common Stock Acquisiton 2012-02-24 1,054 $49.65 6,939 No 4 M Direct
Common Stock Disposition 2012-02-24 1,054 $115.53 5,885 No 4 S Direct
Common Stock Disposition 2012-02-24 166 $116.39 5,719 No 4 F Direct
Common Stock Disposition 2012-02-24 168 $116.39 5,551 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 F Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2012-02-23 1,223 $0.00 1,223 $0.00
Common Stock Stock Option (Right to Buy) Disposition 2012-02-24 1,054 $0.00 1,054 $49.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,446 2014-02-23 No 4 M Direct
1,054 2019-02-24 No 4 M Direct
Footnotes
  1. Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
  3. The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 02/24/09.